Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $116,305,193.67
- Sept. 19, 2025
- Cedric Francois
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 17, 2023 | Director | 1,250 | $64.03 | Sell | $80,037.50 | |
| March 8, 2023 | Insider | 12,000 | $63.79 | Sell | $765,480.00 | |
| Feb. 23, 2023 | Insider | 1,646 | $68.76 | Sell | $113,178.96 | |
| Feb. 8, 2023 | Insider | 12,000 | $54.45 | Sell | $653,400.00 | |
| Feb. 3, 2023 | Insider | 5,000 | $55.85 | Sell | $279,250.00 | |
| Jan. 30, 2023 | Insider | 883 | $52.76 | Sell | $46,587.08 | |
| Jan. 23, 2023 | Insider | 2,955 | $51.58 | Sell | $152,418.90 | |
| Jan. 17, 2023 | Director | 1,250 | $52.42 | Sell | $65,525.00 | |
| Jan. 9, 2023 | Insider | 12,000 | $46.08 | Sell | $552,960.00 | |
| Jan. 5, 2023 | Insider | 2,500 | $48.79 | Sell | $121,975.00 | |
| Jan. 3, 2023 | Insider | 5,000 | $50.70 | Sell | $253,500.00 | |
| Jan. 3, 2023 | Director | 500 | $50.70 | Sell | $25,350.00 | |
| Dec. 19, 2022 | CEO | 28,200 | $52.06 | Sell | $1,468,092.00 | |
| Dec. 15, 2022 | Director | 1,250 | $52.35 | Sell | $65,437.50 | |
| Dec. 8, 2022 | Insider | 12,000 | $47.50 | Sell | $570,000.00 | |
| Dec. 5, 2022 | Insider | 5,000 | $50.38 | Sell | $251,900.00 | |
| Dec. 1, 2022 | Insider | 2,500 | $49.93 | Sell | $124,825.00 | |
| Dec. 1, 2022 | Director | 500 | $49.93 | Sell | $24,965.00 | |
| Nov. 8, 2022 | Insider | 12,000 | $46.47 | Sell | $557,640.00 | |
| Nov. 3, 2022 | Insider | 5,000 | $58.54 | Sell | $292,700.00 | |
| Oct. 14, 2022 | Director | 1,250 | $59.31 | Sell | $74,137.50 | |
| Oct. 10, 2022 | Insider | 12,000 | $57.50 | Sell | $690,000.00 | |
| Oct. 3, 2022 | Insider | 2,500 | $66.69 | Sell | $166,725.00 | |
| Sept. 15, 2022 | Director | 1,250 | $66.00 | Sell | $82,500.00 | |
| Sept. 8, 2022 | Insider | 12,000 | $63.98 | Sell | $767,760.00 | |
| Aug. 17, 2022 | SVP | 5,000 | $69.50 | Sell | $347,500.00 | |
| Aug. 15, 2022 | Insider | 12,500 | $69.00 | Sell | $862,500.00 | |
| Aug. 15, 2022 | Director | 1,250 | $67.21 | Sell | $84,012.50 | |
| Aug. 11, 2022 | Insider | 12,500 | $67.00 | Sell | $837,500.00 | |
| Aug. 11, 2022 | Director | 30,000 | $65.63 | Sell | $1,968,900.00 | |
| Aug. 11, 2022 | SVP | 5,000 | $67.00 | Sell | $335,000.00 | |
| Aug. 3, 2022 | Insider | 5,000 | $56.43 | Sell | $282,150.00 | |
| Aug. 1, 2022 | Insider | 2,500 | $55.99 | Sell | $139,975.00 | |
| July 27, 2022 | SVP | 5,000 | $57.00 | Sell | $285,000.00 | |
| July 19, 2022 | SVP | 5,000 | $56.42 | Sell | $282,100.00 | |
| July 15, 2022 | Director | 1,250 | $46.33 | Sell | $57,912.50 | |
| July 15, 2022 | N/A | 1,250 | $46.33 | Sell | $57,912.50 | |
| July 8, 2022 | Chief Scientific Officer | 12,000 | $47.95 | Sell | $575,400.00 | |
| June 27, 2022 | Director | 1,341 | $46.79 | Sell | $62,745.39 | |
| June 23, 2022 | Director | 15,000 | $45.00 | Sell | $675,000.00 | |
| June 22, 2022 | General Counsel | 10,000 | $44.51 | Sell | $445,100.00 | |
| June 17, 2022 | Insider | 2,698 | $45.00 | Sell | $121,410.00 | |
| June 16, 2022 | SVP | 10,000 | $41.78 | Sell | $417,800.00 | |
| June 15, 2022 | Director | 1,250 | $39.29 | Sell | $49,112.50 | |
| June 1, 2022 | Insider | 2,500 | $41.78 | Sell | $104,450.00 | |
| May 27, 2022 | Insider | 10,000 | $43.00 | Sell | $430,000.00 | |
| May 16, 2022 | Director | 1,250 | $39.18 | Sell | $48,975.00 | |
| May 2, 2022 | Insider | 2,500 | $43.56 | Sell | $108,900.00 | |
| April 29, 2022 | Insider | 4,000 | $44.43 | Sell | $177,720.00 | |
| April 25, 2022 | General Counsel | 5,000 | $50.00 | Sell | $250,000.00 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Cedric Francois, Alec Machiels, Federico Grossi, Pascal Deschatelets, David O Watson, A. Sinclair Dunlop, Mark Jeffrey Delong, Timothy Eugene Sullivan, James George Chopas, Adam J Townsend, Lukas Scheibler, Jeffrey Eisele, Nur Nicholson, Nicole D Perry, Morningside Venture Investment, Karen Lewis, Caroline Baumal, Machiels Alec, Global Strategic Fund I Venbio, Deschatelets Pascal, Victoria L Brown, and Victoria L. Brown
The most active insider trader at Apellis Pharmaceuticals Inc is Cedric Francois with 32 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $46,527,040.87.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on Sept. 19, 2025.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.
